QDRO
← Ingredients

Antibacterial · Zinc Gluconate · CAS 4468-02-4

Zinc Gluconate

The most bioavailable zinc salt for oral use — inhibits enzymes that synthesise volatile sulphur compounds (VSC) and suppresses plaque formation. Outperforms zinc chloride at equivalent doses.

QDRO position

We use it

Best zinc source against halitosis — outperforms chloride in bioavailability

Effective concentration

0.5–1%

Typical on market: 0.5–1%

Zinc Gluconate

Halitosis is a problem that cannot be solved with "fresh" flavour or alcohol alone. Most products mask odour for 20–30 minutes, after which VSC-producing bacteria resume their activity at the same intensity. Zinc works differently: it attacks not the odour but the biochemical mechanism of its formation, and does so for several hours.

What It Is

Zinc gluconate is an organic zinc salt: a Zn²⁺ ion bound to two molecules of gluconic acid (C₁₂H₂₂O₁₄Zn, MW = 455.7 g/mol). It is highly water-soluble (up to 6–10% at 20°C) and provides full ionisation at neutral pH.

Comparison of zinc forms for oral use:

| Form | Solubility | Zn²⁺ bioavailability | Taste | |---|---|---|---| | Gluconate | High | High | Neutral | | Citrate | Moderate | High | Mild acidic | | Chloride | High | Moderate | Metallic | | Oxide | Low | Low | Neutral | | Pyrithione | Low | Specific | Bitter |

Gluconate and citrate are the preferred forms for mouthwashes and pastes: maximum free Zn²⁺ ions at a neutral taste profile.

How It Works

Inhibition of VSC-producing enzymes. The primary volatile sulphur compounds — H₂S, CH₃SH (methyl mercaptan), (CH₃)₂S — are formed by bacterial degradation of sulphur-containing amino acids (cysteine, methionine) by the enzymes cysteine desulphidase and β-cystathionase. The Zn²⁺ ion coordinates to the active sites of these enzymes (rich in thiol and histidine groups), reversibly inhibiting their activity. Saad et al. (2011, PMID 21300341) demonstrated that 0.1% Zn²⁺ reduced H₂S and CH₃SH production from cysteine in vitro by 80–90%.

Binding of pre-formed VSC. Zn²⁺ ions are soft Lewis acids with high affinity for soft bases (thiol and sulphide groups). They form stable, non-volatile complexes with already-present VSC molecules, transferring them from the gas phase to a bound state. This explains zinc's rapid (within minutes) effect on odour — before enzymatic inhibition has fully taken effect.

Anti-plaque action. Zn²⁺ inhibits S. mutans glucosyltransferases (similar to lactoferrin), disrupts bacterial aggregation in biofilm, and reduces tartar formation rate by binding to phosphate groups in hydroxyapatite crystals that would otherwise serve as nucleation sites.

Efficacy

VSC inhibition in vitro (PMID: 21300341)

Saad et al. (2011): comparison of zinc gluconate vs. zinc chloride and control at equivalent Zn²⁺ concentrations. Gluconate outperformed chloride in VSC inhibition from cysteine and methionine at all tested concentrations (0.01–0.1%). The difference is explained by more complete ionisation of gluconate in saliva — complexation with the organic anion provides better buffering of Zn²⁺ against premature precipitation.

Clinical RCT — zinc gluconate mouthwash (PMID: 11684039)

Young et al. (2001): 30 subjects with morning halitosis, VSC assessment before and after a 0.2% Zn-gluconate oral gel. Total VSC reduction (H₂S + CH₃SH) at 1 hour: –57% vs. –23% in control (no zinc). Effect persisted for up to 3 hours.

Comparative treatment modality study (PMID: 22385275)

Erovic Ademovski et al. (2012): 40 patients with halitosis, 5 treatment arms (mechanical tongue cleaning, antiseptic rinses, zinc-containing pastes). Zinc mouthwash and chlorhexidine showed comparable VSC reduction at 4 hours post-application; zinc delivered this without chlorhexidine's adverse effects (staining, dysgeusia).

Periodontitis and halitosis (PMID: 12296778)

Quirynen et al. (2002): patients with periodontitis receiving SRP + zinc-containing antiseptic mouthwashes showed more pronounced reduction in organoleptic halitosis scores compared to SRP without zinc.

Safety

Zinc is an essential micronutrient required by more than 300 human enzymes. Zinc gluconate:

  • Listed in EU CosIng without concentration restrictions
  • GRAS status (FDA, food supplement)
  • Safe for topical use at concentrations of 0.1–2%
  • Systemic zinc toxicity begins at oral intake > 40 mg/day (EFSA UL for adults); topical toothpaste/mouthwash use delivers negligible systemic absorption
  • Possible metallic aftertaste at concentrations > 0.5% — neutralised by flavouring agents or the gluconate organic anion itself

Role in the QDRO Formula

Zinc gluconate is an essential anti-halitosis component for QDRO mouthwashes. In an anti-halitosis product it operates as a dual-action system:

  • Rapid effect (0–30 min): complexation with pre-formed VSC molecules
  • Sustained effect (1–4 h): enzymatic inhibition of VSC production

Optimal concentration in mouthwash: 0.5–1.0% as zinc gluconate (≈0.07–0.14% Zn²⁺). In toothpaste: 0.5%.

Paired with Streptococcus salivarius K12, zinc gluconate creates immediate + sustained halitosis control: zinc inhibits VSC instantly, while K12 displaces VSC producers over the long term.

Brand verdict: we use it — the priority active component in the QDRO anti-halitosis line.


Sources:

  • Waler SM. (1997). On the transformation of sulfur-containing amino acids and peptides to volatile sulfur compounds in the human mouth. Eur J Oral Sci. PMID: 9395091
  • Saad S et al. (2011). In vitro volatile sulphur compounds production from cysteine and methionine with and without zinc gluconate. Arch Oral Biol. PMID: 21300341
  • Young A et al. (2001). Volatile sulfur-containing compounds in morning bad breath: influence of an antibacterial zinc gluconate gel mouthrinse. Arch Oral Biol. PMID: 11684039
  • Erovic Ademovski S et al. (2012). Comparison of different treatment modalities for oral halitosis. Acta Odontol Scand. PMID: 22385275
  • Quirynen M et al. (2002). The impact of periodontal therapy and antiseptics on breath odour. J Clin Periodontol. PMID: 12296778